fda news - Search News

In a Victory for the Free Market, FDA Approves New Schizophrenia Drug

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.

WTXL ABC 27 · 2m

FDA approves first new medication to treat schizophrenia in more than 30 years

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental illness in more than 30 years.

CNBC on MSN · 3h

Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug

CNBC's Angelica Peebles joins 'Fast Money' to report on Bristol Myers Squibb's stock rise following FDA approval of Cobenfy for treating schizophrenia in adults.

FDA, Dog food and Listeria

YAHOO!News · 2h

Dog food pulled from shelves nationwide: FDA

The U.S. Food and Drug Administration reports a pet food company is voluntarily withdrawing some of their beef and chicken dog food after samples collected by the FDA tested positive for salmonella and listeria monocytogenes.

AOL · 1h

FDA Alert: Dog Food Recall Over Salmonella, Listeria Fears — What Owners Must Do Now

Certain lots of Answers dog food and Darwin's Natural Pet Products, which includes dog and cat food, have been recalled after the FDA tested samples of the brand's pet food, which tested positive for salmonella and listeria. So far, no illnesses related to the recall have been reported, according to the FDA's press release.

MLive · 1d

Nationally distributed dog food recalled over possible listeria, salmonella contamination

The Food and Drug Administration announced this week a recall of three types of Answers dog food that was distributed and sold nationwide over concerns of possible listeria and salmonella contamination.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 1d

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 1d

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 1d

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

4hon MSNOpinion

Column: A federal appeals court hands the FDA a stupendous win in its battle against stem cell clinics

Just as it began to seem that the battle against pseudoscience in medicine was being lost, a federal appeals court in San ...

STAT4h

The FDA is ‘making sandwiches,’ ‘breakfast salad’ in DC, and what keeps us from choking on food

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

Courthouse News Service2h

Ninth Circuit sides with FDA in oversight of ‘liquid magic’ stem cell therapy

The panel agreed with the FDA that the treatment in which a patient's tissue is processed doesn't fall under the same ...

10hon MSN

Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

JD Supra6h

FDA Issues Multiple Guidances Supporting Clinical Trial Innovation

In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...

MedPage Today9h

COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says

The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...

Medscape10h

FDA OKs First-in-Class Antipsychotic for Schizophrenia

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics